Tvardi Therapeutics, Inc. (TVRD)
NASDAQ: TVRD · Real-Time Price · USD
1.150
-0.090 (-7.26%)
At close: Oct 2, 2026, 4:00 PM EDT
1.170
+0.020 (1.74%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Tvardi Therapeutics Market Cap
Tvardi Therapeutics has a market cap or net worth of $15.34 million as of October 2, 2026. Its market cap has decreased by -95.67% in one year.
Market Cap
15.34M
Enterprise Value
-280.22K
1-Year Change
-95.67%
Ranking
Category
Stock Price
$1.15
ChartMarket Cap Chart
Since April 16, 2025, Tvardi Therapeutics's market cap has decreased from $170.73M to $15.34M, a decrease of -91.01%. That is a compound annual growth rate of -80.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 15.34M | -61.97% |
| Dec 31, 2025 | 40.34M | -76.37% |
| Apr 16, 2025 | 170.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Marker Therapeutics | 17.59M |
| Cellectar Biosciences | 17.49M |
| Lipocine | 17.15M |
| NewcelX | 17.04M |
| Palatin Technologies | 16.76M |
| Pasithea Therapeutics | 16.73M |
| Allarity Therapeutics | 16.71M |
| SeaStar Medical Holding | 16.46M |